cslbehring.ca
HomeCSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases worldwide
http://www.cslbehring.ca/
CSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases worldwide
http://www.cslbehring.ca/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.5 seconds
PAGES IN
THIS WEBSITE
11
SSL
EXTERNAL LINKS
187
SITE IP
12.3.33.46
LOAD TIME
0.542 sec
SCORE
6.2
Home | cslbehring.ca Reviews
https://cslbehring.ca
CSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases worldwide
cslbehring.ca
CSL Behring offers plasma derived and recombinant therapies
http://www.cslbehring.ca/canadian-products-monographs
Include All CSL Behring Country Sites. Canadian Products & Monographs. Research & Development. Commitment to Quality & Safety. Canadian Products and Monographs. We offer a wide range of plasma-derived and recombinant therapeutic products including a variety of products used in the hospital setting for critical care, for primary immunological disorders, and as thrombolytic agents. Cytomegalovirus Immune Globulin Intravenous (HUMAN) (CMV-IGIV). Factor XIII Concentrate, Human. Routine prophylaxis to prevent...
Plasma Collection Safety & Quality Standards at CSL Behring & ZLB Plasma
http://www.cslbehring.ca/quality-safety
Include All CSL Behring Country Sites. Canadian Products & Monographs. Research & Development. Commitment to Quality & Safety. Commitment to Quality and Safety. Commitment to Quality and Safety. We believe our products have never been safer than they are today due to substantial investments in product safety, manufacturing facility enhancements, and research and development activities. In fact, during the past 25 years, the risk of virus transmission through plasma-derived products has been nearly el...
All CSL Behring Web Sites
http://www.cslbehring.ca/all-csl-behring-web-sites
Include All CSL Behring Country Sites. Canadian Products & Monographs. Research & Development. Commitment to Quality & Safety. All CSL Behring Web Sites. All CSL Behring Web Sites. CSL Behring in Austria. CSL Behring in Brazil. CSL Behring in Canada. CSL Behring in China. CSL Behring in Denmark. CSL Behring in France. CSL Behring in Germany. CSL Behring in Italy. CSL Behring in Japan. CSL Behring in Mexico. CSL Behring in Nordic Countries. CSL Behring in Spain. CSL Behring in Switzerland.
CSL Behring is a Leader in the Plasma Protein Biotherapeutics Industry
http://www.cslbehring.ca/about
Include All CSL Behring Country Sites. Vision & Values. Environmental, Health & Safety. Canadian Products & Monographs. Research & Development. Commitment to Quality & Safety. CSL Behring global product portfolio (PDF, 24KB). About Emil von Behring, our founder. Plasma industry cost structure. CSL Code of Responsible Business Practice. CSL Corporate Responsibility Report. Our biotherapies are indicated for the treatment of rare diseases such as hemophilia and other bleeding disorders, primary immune defi...
CSL Behring Press Releases and Corporate Communications
http://www.cslbehring.ca/news-room
Include All CSL Behring Country Sites. Canadian Products & Monographs. Research & Development. Commitment to Quality & Safety. The most recent items of news in the Canadian Region are:. CSL Canada is supporting Missing Type campaign. Our web site does have missing letters, join the Canadian Blood Services Missing Type campaign. More. CSL Behring Commemorates 2016 hae day :-) with Partnerships, Sponsorships and Hereditary Angioedema Awareness Events. Vial format. More. Primary immunodeficiencies (PI) occu...
TOTAL PAGES IN THIS WEBSITE
11
Von Willebrand Disease
http://www.cslbehring.se/s1/cs/bese/1252899238848/content/1252899231141/content.htm
Include All CSL Behring Country Sites. Physicians & Health Care Professionals. Patients & Families. Haemolytic disease of the newborn. Congenital Factor XIII Deficiency. People with von Willebrand disease. VWD) have a problem with one of the clotting factors in the blood; this particular clotting factor is known as von Willebrand factor. In people unaffected by von Willebrand disease, this clotting factor helps platelets stick to the wall of the damaged blood vessel and assists the glue-like clotting.
全球导航
http://www.cslbehring.com.cn/global-navigation
Please check with your local country to see if products or programs are available in your area. CSL Behring in Austria. CSL Behring in Brazil. CSL Behring in Canada. CSL Behring in Germany. CSL Behring in Japan. CSL Behring in Nordic Countries. CSL Behring in Spain. CSL Behring in Switzerland. CSL Behring in United Kingdom. CSL Behring in United States. Gap Insurance, USA). ZLB Behring Customer Service. BeriNet (Hereditary Angioedema,. Helixate FS (Hemophilia Moms). Humate-P (von Willebrand Disease).
Immunoglobulin, IVIg & SCIg | CSL Behring
http://www.cslbehring.com/s1/cs/enco/1255923358055/page/1255923357721/TabsLandingPage.htm
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring offers one of the world's most comprehensive portfolios of safe, high quality, technically advanced immunoglobulin (Ig) products designed to offer patients the convenience, choice, and ease of administration that they seek. The body's immune system can then work more effectively. CSL Behring Immunoglobulin Products. The CSL Behring product portfolio includes key immu...
Physicians & Health Care Professionals
http://www.cslbehring.se/s1/cs/bese/1164719155492/content/1164719155034/content.htm
Include All CSL Behring Country Sites. Physicians & Health Care Professionals. CSL Behring Nordic VW Scholarship. Patients & Families. Physicians and Health Care Professionals. Physicians and Health-care Professionals. Welcome to our section for physicians and health-care professionals. Here you will find information about our medicinal products as well as access to scientific literature, and links to further relevant information. The Patient and Families. If you have any questions.
Privacy Policy
http://www.cslbehring.se/s1/cs/bese/1160484846607/content/1160484846331/content.htm
Include All CSL Behring Country Sites. Physicians & Health Care Professionals. Patients & Families. Thank you for visiting www.cslbehring.se. Information Collected from You. How to Contact Us. Information Collected from You. Only when you specifically request it will the information that we collect be used to respond to your questions, or to fulfill e-mail messaging programs, and notify visitors about new content or services on our Web sites. The domain and host from which you access the Internet. You ma...
CSL Behring
http://www.cslbehring.se/s1/cs/bese/1160484846586/page/1252899180566/HomepageTemplate.htm
Include All CSL Behring Country Sites. Physicians & Health Care Professionals. Patients & Families. CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. The company develops, manufactures and markets a range of products for the following therapy areas:. Products for the treatment of Congenital FXIII Deficiency, Congenital Fibrinogen Deficiency, Haemophilia, Rapid Warfarin Reversal and von Willebrand Disease. Congenital Factor XIII Deficiency.
CSL Behring: Global Life Saving Biotherapies, Plasma Protein Biotherapeutics
http://www.cslbehring.com/s1/cs/enco/1151443990667/content/1151443991017/home.htm
All CSL Behring Web Sites. Health, Safety & Environment. Quality & Safety. CSL Research & Development. Other Areas of Business. CSL Behring develops, manufactures and markets protein based therapies, including:. Hereditary Angioedema (HAE) Therapies. Paul Perreault Talks About Innovation. Paul Perreault on Bloomberg News: "If you're not innovating in this rare disease space, you're planning your exit.". Tim’s Story: Outdoor Adventurer Remains Active Despite Hemophilia.
CSL completes Novartis influenza vaccine business acquisition
http://www.csl.com.au/Investors/CSL-Completes-Novartis-Influenza-Vaccine-Business-Acquisition.htm
CSL Plasma Services (Germany). R&D and Operational Briefings. CSL completes Novartis influenza vaccine business acquisition. CSL completes Novartis influenza vaccine business acquisition. CSL Limited (ASX:CSL; USOTC: CSLLY) today announced that it has now closed its transaction to acquire Novartis global influenza vaccine business for a cash consideration of US$275 million. As foreshadowed in CSL’s release to the Australian Securities Exchange on 31 July. For further information, please contact:.
CSL - Financial Reports
http://www.csl.com.au/investors/financial-reports.htm
CSL Plasma Services (Germany). R&D and Operational Briefings. Half Year Report 2015-2016. As CSL reaches a remarkable milestone this year, marking 100 years of developing and delivering innovations to help patients live life to the fullest, I am pleased to report an exceptional first half year result. For the six months ended 31 December 2015, CSL reported net profit after tax of US$719 million, an increase of US$27 million (4% on a reported basis) on the same period last year. Half Year Report 2015-2016.
TOTAL LINKS TO THIS WEBSITE
187
一押しの借入先はこちら
CSLBD – Largest PABX Solution Provider Since 1989
Call Us Now : 02 58155056, 02 58155818. Call center with IVR and CRM. CSL We specialize in. Let us help you implement the right Telecom and IT solution for your business. CSL is the leading PABX solution provider in Bangladesh with over 250 Customers. Our current customer includes ARMY, NAVY, Air Force, National Banks and Hotels. New high speed document imaging. CSL is now offering customer highspeed document imaging solution. Browser Phone system solution. Bangladesh Bank Project with TSS. CSL Head offi...
CSL Behring USA| Life Saving Biotherapies| Plasma Protein Biotherapeutics
CSL Behring US Web Sites. Include All CSL Behring Country Sites. CSL Behring - USA Homepage. CSL Behring develops, manufactures and markets protein based therapies, including:. Coagulation and Bleeding Disorders. Critical Care and Immunology. View All US Products. Paul Perreault Talks About Innovation. Paul Perreault on Bloomberg News: "If you're not innovating in this rare disease space, you're planning your exit.". Interview with CSL CEO Paul Perreault on FOX Business News. PI) in patients with A.
CSL Behring Österreich - Homepage
We use cookies to improve the function of this site and enhance the user experience. About our cookie policy and how to modify your cookie settings. Alle CSL Behring Webseiten einschließen. Qualität & Sicherheit. Wissenswertes über unsere Therapien. CSL Behring - Biotherapies for Life. Alle Termine und Koordinaten der CSL Behring Gerinnungsrunden. Vortäge der Gerinnungsrunden können, soweit verfügbar, hier nachgelesen werden. Wir unterstützen OKids - das österreichische Kinderforschungsnetzwerk.
Homepage NL
Zoeken in alle CSL Behring-websites. CSL Behring zet zich in om wereldwijd levens te redden en de kwaliteit van leven te verbeteren van mensen met zeldzame en ernstige aandoeningen. Meet LINX. Your Link to Hemophilia.
Home
Include All CSL Behring Country Sites. Canadian Products & Monographs. Research & Development. Commitment to Quality & Safety. CSL Behring is committed to improving the quality of life for patients with rare and serious diseases. CSL Behring and our parent company, CSL Limited, continue to build on a long legacy of innovation in patient care. Driven by our Promise. We are a company known for keeping our promises. Approved for Pediatric Pateints. Berinert 1500 IU Announcement. All CSL Behring Web Sites.
CSL Behring - Biotherapies for Life
Alle CSL Behring Seiten. Alle CSL Behring Webseiten einschliessen. News & Veranstaltungen. Jobs & Karriere. Wie Sie uns finden. CSL Behring - Biotherapies for Life. CSL Behring entwickelt, produziert und vertreibt Biotherapeutika für die Indikations- und Therapiebereiche:. CSL Behring in Lengnau. CSL Behring erstellt in Lengnau im Kanton Bern eine neue Produktionsstätte für rekombinante Gerinnungsfaktoren: .
CSL Behring - UK Homepage
The website for CSL Behring UK Ltd is being updated and will be available shortly. Please contact CSL Behring using the details on this page and we will reply as soon as possible. For information on clinical trials or the transfer of value made by CSL Behring UK in the last financial year phone 01444 447 405. Tel: 01444 447 402 / 422. Email: CSL Behring UK Customer Service. Date of preparation: June 2015.
CSL Behring | Global Life Saving Biotherapies, Plasma Protein Biotechnology
Leading the Way on Rare and Serious Diseases. The CSL Behring Commitment. The CSL Behring Commitment. Workplace Health and Safety. Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility. It is our mission is to discover, develop, and deliver innovative therapies that improve patients quality of life. Immunodeficiency and Autoimmune Diseases. Alpha 1 Antitrypsin Deficiency. Patient Programs in USA. LEAD Grants and Raise Your Voice USA. Vita mea...
CSL Behring Argentina
Incluir todos los sitios de CSL Behring. Acerca de CSL Behring. Exclusivo para Profesionales de la Salud. CSL Investigación y desarrollo. Compromiso con el paciente. TÉRMINOS Y CONDICIONES DEL SITIO www.cslbehring.com.ar. Bienvenido al Sitio de Internet de CSL Behring Argentina. Los Términos y Condiciones podrán ser periódicamente modificados y actualizados por CSL BEHRING sin notificación previa al Usuario ni a ninguna otra persona física o jurídica. CSL BEHRING podrá, sin necesidad de notificación prev...
